#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Solitary fibrous tumour Mycobacterium abscessus infection Transitional cell carcinoma Colitis ulcerative Pseudomyxoma peritonei Congenital disorder of glycosylation Small intestine adenocarcinoma Loeys-Dietz syndrome Oesophageal squamous cell carcinoma stage III Superficial vein thrombosis Peritoneal mesothelioma malignant Non-Hodgkin's lymphoma refractory Krabbe's disease Ischaemic stroke Lennox-Gastaut syndrome More trials…

    Learn about Rare Diseases

    Adrenocortical carcinoma – Life with Disease Extranodal marginal zone B-cell lymphoma (MALT type) Marginal zone lymphoma – Trials in Disease Chordoma – Life with Disease Systemic sclerosis pulmonary – Treatment Sarcoidosis Paraneoplastic neurological syndrome – Treatment Antithrombin III deficiency – Basic Information Methylmalonic acidaemia – Life with Disease Factor VIII deficiency – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Hyoscine RO7268489 Carbidopa Triamcinolone Acetonide S230815-2 Gskvx000000014593 CAMOSTAT MESILATE Alxn2220 Lurbinectedin Vrdn-001 Pivekimab Sunirine Ginisortamab VG801-1 Resiquimod Sulfate Pervi-Neo Brigatinib Immunostimulants Pp1815 Gs-1427 Minocycline Hydrochloride More therapies…

    Learn about Your Condition

    Hypersensitivity Cholangiocarcinoma Peripheral artery stenosis Bacterial infection Cutaneous lupus erythematosus High-grade B-cell lymphoma Upper limb fracture Corneal graft failure Substance use disorder Primary adrenal insufficiency Coagulopathy Bacterial vaginosis Precocious puberty Right ventricular dysfunction Malignant melanoma stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study of the humanised IgG1 lalaps-yte monoclonal antibody against lysophosphatidic acid receptor 1 to treat adults with idiopathic pulmonary fibrosis

    Recruiting

    2 1
    Investigated Drugs:
    • HUMANISED IGG1 LALAPS-YTE MONOCLONAL ANTIBODY AGAINST LYSOPHOSPHATIDIC ACID RECEPTOR 1
    Bulgaria France Germany Greece Hungary Italy +5

  • A study to evaluate the safety and effects of palopegteriparatide in adolescents with chronic hypoparathyroidism

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Palopegteriparatide
    France Germany Poland Romania

  • A Phase 3 study to evaluate the efficacy and safety of ION582 in children and adults with Angelman syndrome

    Recruiting

    3 1 1
    Investigated Diseases:
    • Angelman’s syndrome
    Investigated Drugs:
    • 2′-O-(2-Methoxyethyl) Modified Antisense Oligonucleotide Targeting Ube3A Antisense Transcript Rna
    Germany Italy Poland Spain

  • A study to evaluate the safety and effectiveness of galvokimig in adults with moderate to severe atopic dermatitis

    Recruiting

    2 1
    Investigated Diseases:
    • Dermatitis atopic
    Bulgaria Czechia Germany Hungary Poland

  • A study of JNJ-78278343 and docetaxel compared to docetaxel and prednisone in patients with metastatic castration-resistant prostate cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Docetaxel
    • Prednisone
    Belgium France Germany Italy Spain

  • Study of Sotorasib, Panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Panitumumab
    • Sotorasib
    • Bevacizumab
    Austria Belgium Bulgaria Czechia Denmark Estonia +12
Previous Page
1 … 46 47 48 49 50 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!